Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
02/2015
02/03/2015US8946290 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
01/2015
01/14/2015CN104274442A 癌症的治疗 Treatment of cancer
01/08/2015US20150011563 Treating Sexual Desire Disorders with Flibanserin
01/06/2015US8926985 Vaccine
01/06/2015CA2421998C Vaccine against streptococcus pneumoniae
01/01/2015US20150005320 Compounds for inflammation and immune-related uses
12/2014
12/30/2014USRE45313 Exendin variant peptides
12/25/2014US20140378465 Method of treating diabetes
12/02/2014US8901303 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/02/2014US8901130 Low hygroscopic aripiprazole drug substance and processes for the preparation
11/2014
11/13/2014US20140336356 Peptide agonists of glp-1 activity
11/11/2014US8883750 Method of treating diabetes
11/04/2014US8877771 Treatment of solid tumors with rapamycin derivatives
10/2014
10/16/2014US20140309236 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
10/02/2014US20140296258 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibiton
10/02/2014US20140294763 Peptidomimetic protease inhibitors
09/2014
09/30/2014US8846026 Composition comprising immunogenic microparticles
09/25/2014US20140286878 Composition for inhalation
09/18/2014US20140271541 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
08/2014
08/13/2014EP2764865A2 Cancer treatment
08/06/2014EP2762140A1 Treatment of solid brain tumours with a rapamycin derivative
08/06/2014CN101670105B 螯合淀粉样蛋白β肽的人源化抗体 Human amyloid β peptide chelating humanized antibody
08/05/2014CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine
07/2014
07/29/2014CA2697205C Peptidomimetic protease inhibitors
07/15/2014US8778962 Treatment of solid tumors with rapamycin derivatives
07/03/2014US20140187772 Pyrazole compounds useful as protein kinase inhibitors
06/2014
06/18/2014CN102526079B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
06/10/2014US8748476 Darifenacin for use in the treatment of urgency induced by overactive bladder
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
05/2014
05/21/2014CN101675992B β-淀粉样蛋白-类似物-T-细胞表位疫苗 β- amyloid - like -T- cell epitope vaccine
05/01/2014US20140121228 Quinazoline Derivatives as VEGF Inhibitors
04/2014
04/30/2014CN101843897B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
04/30/2014CN101633655B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
04/22/2014US8703773 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/22/2014US8703212 Base material for pharmaceutical and/or cosmetic cream (herbal composition for itchy or infected skin)
04/17/2014US20140107134 Compounds for inflammation and immune-related uses
04/17/2014US20140105895 Treatment of solid tumors with rapamycin derivatives
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/10/2014US20140099339 Vaccine against streptococcus pneumoniae
03/2014
03/04/2014CA2526490C Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
02/2014
02/27/2014US20140057923 Treating Sexual Desire Disorders with Flibanserin
02/27/2014DE60000133C5 Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen Essential fatty acids for the prevention of cardiovascular attacks
02/04/2014US8642760 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
02/04/2014US8642608 Quinazoline derivatives as VEGF inhibitors
01/2014
01/30/2014US20140030523 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/2013
12/19/2013US20130338148 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
11/2013
11/28/2013US20130315863 Methods and compositions for treating flaviviridae infections
11/26/2013US8591894 Humanized antibodies that sequester amyloid beta peptide
11/21/2013US20130310336 Methods and compositions for treating flaviviruses and pestiviruses
11/12/2013US8580796 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/07/2013US20130296359 Treatment of solid tumors with rapamycin derivatives
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575137 Composition for inhalation
10/2013
10/31/2013US20130287769 Treatment of solid tumors with rapamycin derivatives
10/08/2013US8552016 Anti-cancer cyclopenta(g)quinazoline compounds
10/01/2013US8545468 Component for forming a seal around an opening in the skin
09/2013
09/26/2013US20130253000 Treatment of solid tumors with rapamycin derivatives
09/24/2013US8541429 Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors
09/24/2013CA2490100C Pharmaceutical formulation for use in treating drug withdrawal and preparation method
09/19/2013US20130244951 Treatment of solid tumors with rapamycin derivatives
09/10/2013US8529882 Peptidomimetic protease inhibitors
08/2013
08/28/2013CN101423492B Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same
08/15/2013US20130210722 Methods for using peptide agonists having glp-1 activity
08/14/2013CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof
08/07/2013CN103232381A Peptidomimetic protease inhibitors
08/01/2013US20130195890 Treatment of ms with goat serum
07/2013
07/24/2013CN1705740B Adenovirus expressing genes in reverse order and use thereof
07/16/2013US8486955 Anti-cancer cyclopenta [g] quinazoline compounds
07/04/2013US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
07/03/2013CN101502648B Vaccine
07/03/2013CN101445555B Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
06/2013
06/19/2013CN101305990B Use of EDG receptor binding agents in cancer
06/18/2013US8466175 Form of S-omeprazole
06/18/2013US8466139 Formulation
06/18/2013CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
06/18/2013CA2422002C Vaccine
05/2013
05/29/2013CN1826121B Use of phenyl and pyridyl derivative for modulating calcium ion-release-activated calcium ion channels
05/07/2013US8436010 Treatment of solid tumors with rapamycin derivatives
05/02/2013US20130109702 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
05/01/2013EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor
04/2013
04/25/2013US20130102555 Method of treating diabetes
04/24/2013CN1869061B Peptidomimetic protease inhibitors
04/18/2013US20130096137 Treating Sexual Desire Disorders with Flibanserin
04/18/2013US20130096128 Pyrazole compounds useful as protein kinase inhibitors
04/02/2013US8410131 Cancer treatment
04/02/2013CA2533594C Compounds for inflammation and immune-related uses
03/2013
03/21/2013US20130072503 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
03/19/2013US8399469 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/13/2013CN101633636B Peptidomimetic protease inhibitors
03/13/2013CN101434572B Prodrugs of GABA analogs, compositions and uses thereof
03/12/2013CA2503383C Extended, controlled release pharmaceutical compositions comprising charged polymers
03/07/2013US20130059877 Treatment of solid tumors with rapamycin derivatives
01/2013
01/01/2013US8343937 Methods and compositions for treating flaviviruses and pestiviruses
12/2012
12/27/2012US20120329766 Formulation
12/26/2012CN1826333B Diamine derivatives
12/19/2012CN101301475B Peg化因子vii糖型 Peg factor vii sugar type
12/13/2012US20120316180 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316179 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120315302 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/11/2012US8329680 Formulation
1 2 3 4 5 6 7 8 9 10 11 ... 32